Right ventricular outflow tract revalvulation using the Melody Valve: The next frontier
Congenital heart lesions with abnormal right ventricular outflow tract anatomy will require early surgical intervention. Re-intervention rates in these patients are high due to homograft degeneration. Until recently, surgery was the only treatment option for right ventricular outflow tract dysfuncti...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
South African Heart Association
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8201b85255944a76ab85506d36a776be |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sumario: | Congenital heart lesions with abnormal right ventricular outflow tract anatomy will require early surgical intervention. Re-intervention rates in these patients are high due to homograft degeneration. Until recently, surgery was the only treatment option for right ventricular outflow tract dysfunction. Percutaneous pulmonary valve implantation has been introduced as a new therapeutic alternative to prolong conduit life span and to reduce surgical re-intervention rates. Short- and mid-term results have been favourable and showed that it is a safe and effective therapy. These are reviewed with emphasis on the Melody valve. |
---|